Mercury Systems Launches CANGuard to Strengthen Automotive Data Security
30 janv. 2017 16h19 HE
|
Mercury Systems, Inc.
CHELMSFORD, Mass., Jan. 30, 2017 (GLOBE NEWSWIRE) -- Addressing the need for tighter in-vehicle security, Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com), today announced the CANGuard™ security...
Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico
18 janv. 2017 07h00 HE
|
Apricus Biosciences
SAN DIEGO, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
OSE Immunotherapeutics signs a license option agreement with Servier to develop and commercialize the product Effi-7
27 déc. 2016 18h01 HE
|
OSE Immunotherapeutics
NANTES, France and PARIS, Dec. 27, 2016 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN:FR0012127173) (Mnémo:OSE), today announced that the company has entered into a worldwide license option...
Apricus Biosciences Announces the Launch of Vitaros® for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals
27 déc. 2016 07h00 HE
|
Apricus Biosciences
SAN DIEGO, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the...
MacroGenics Licenses Synthon’s Technology to Develop an Anti-B7-H3 ADC
12 déc. 2016 16h30 HE
|
MacroGenics, Inc.
ROCKVILLE, Md. and NIJMEGEN, the Netherlands, Dec. 12, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing...
Perry Ellis International Announces Boy's Tailored Clothing License for Perry Ellis Brand
08 nov. 2016 09h30 HE
|
Perry Ellis International, Inc.
MIAMI, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Perry Ellis International (Nasdaq:PERY) announced today that it has entered into a license agreement with Peerless Clothing International for boy's...
Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Greece
26 oct. 2016 07h00 HE
|
Apricus Biosciences
SAN DIEGO, Oct. 26, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
Myriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with Diabetes
25 oct. 2016 07h05 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that it will work with Sanofi, a global and...
National Small Business Invests in Technology to Support Unique Concierge Business Model
04 oct. 2016 08h09 HE
|
Best Upon Request
CINCINNATI, Oct. 4, 2016 (GLOBE NEWSWIRE) -- Imagine never having to pick up your dry cleaning, go to the post office or take your car in for an oil change again. That's the reality for employees...
Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati
21 sept. 2016 07h00 HE
|
Apricus Biosciences
SAN DIEGO, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the...